Group CD62L+CCR7-supset (% ± SD) CD62L-CCR7+subset (% ± SD)
HCC 0.04 ± 0.03a 9.97 ± 7.34c
Paracancerous tissue 0.46 ± 0.35b 0.57 ± 0.33
Control 2.44 ± 2.06 1.74 ± 1.93
Note: (a) compared with that of control group, P<0.05; (b) compared with that of control group, P<0.05; (c) compared with that of paracancerous tissue group and control groups.
Table 2: The percentage of CD62L+CCR7-supset and CD62L-CCR7+subset relative to CD4+CD45RO+Tm detected by FCM.